» Articles » PMID: 20102610

Gene Profiling of the Erythro- and Megakaryoblastic Leukaemias Induced by the Graffi Murine Retrovirus

Overview
Publisher Biomed Central
Specialty Genetics
Date 2010 Jan 28
PMID 20102610
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute erythro- and megakaryoblastic leukaemias are associated with very poor prognoses and the mechanism of blastic transformation is insufficiently elucidated. The murine Graffi leukaemia retrovirus induces erythro- and megakaryoblastic leukaemias when inoculated into NFS mice and represents a good model to study these leukaemias.

Methods: To expand our understanding of genes specific to these leukaemias, we compared gene expression profiles, measured by microarray and RT-PCR, of all leukaemia types induced by this virus.

Results: The transcriptome level changes, present between the different leukaemias, led to the identification of specific cancerous signatures. We reported numerous genes that may be potential oncogenes, may have a function related to erythropoiesis or megakaryopoiesis or have a poorly elucidated physiological role. The expression pattern of these genes has been further tested by RT-PCR in different samples, in a Friend erythroleukaemic model and in human leukaemic cell lines.We also screened the megakaryoblastic leukaemias for viral integrations and identified genes targeted by these integrations and potentially implicated in the onset of the disease.

Conclusions: Taken as a whole, the data obtained from this global gene profiling experiment have provided a detailed characterization of Graffi virus induced erythro- and megakaryoblastic leukaemias with many genes reported specific to the transcriptome of these leukaemias for the first time.

Citing Articles

Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes.

Charfi C, Edouard E, Rassart E Cell Oncol (Dordr). 2014; 37(3):179-91.

PMID: 24916915 DOI: 10.1007/s13402-014-0171-y.


Characterization and identification of PARM-1 as a new potential oncogene.

Charfi C, Levros Jr L, Edouard E, Rassart E Mol Cancer. 2013; 12:84.

PMID: 23902727 PMC: 3750824. DOI: 10.1186/1476-4598-12-84.

References
1.
Hao X, Shin M, Zhou J, Lee C, Qi C, Naghashfar Z . Histologic and molecular characterizations of megakaryocytic leukemia in mice. Leuk Res. 2005; 30(4):397-406. DOI: 10.1016/j.leukres.2005.08.021. View

2.
Lecuyer E, Hoang T . SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol. 2004; 32(1):11-24. DOI: 10.1016/j.exphem.2003.10.010. View

3.
Yates K, Gasson J . Role of c-Fes in normal and neoplastic hematopoiesis. Stem Cells. 1996; 14(1):117-23. DOI: 10.1002/stem.140117. View

4.
Yan J, Tsai S, Tsai M . SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin. 2006; 27(4):387-94. DOI: 10.1111/j.1745-7254.2006.00315.x. View

5.
Andonegui G, Kerfoot S, McNagny K, Ebbert K, Patel K, Kubes P . Platelets express functional Toll-like receptor-4. Blood. 2005; 106(7):2417-23. DOI: 10.1182/blood-2005-03-0916. View